FdaApplication
ANDA 205412
Identifiers
- fda_app_no: ANDA205412
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT V |
| application_type | ANDA |
| approval_date | 2025-04-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ABACAVIR SULFATE AND LAMIVUDINE | ABACAVIR SULFATE; LAMIVUDINE | EQ 600MG BASE;300MG | TABLET;ORAL |
1 product